| Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2) (NCT03816839) | Sanofi | 2019-03-25 |
| A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects (NCT03892902) | Idorsia Pharmaceuticals Ltd. | 2019-03-25 |
| A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission (NCT03850535) | Hoffmann-La Roche | 2019-03-25 |
| Prescription Medication Interactions (NCT04315181) | Sharon Walsh | 2019-03-25 |
| Efficacy of Amniotic Membrane Over Pancreatic Anastomosis After Pancreaticoduodenenctomy to Preventing Pancreatic Fistula (NCT03891225) | Casa di Cura Dott. Pederzoli | 2019-03-25 |
| Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402 (NCT03921268) | AstraZeneca | 2019-03-25 |
| Nutritional Intervention With Table Olives in Healthy Volunteers (NCT03886597) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2019-03-25 |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL (NCT03349281) | Julio Barredo, MD | 2019-03-25 |
| Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions (NCT03915340) | Pharmtechnology LLC | 2019-03-23 |
| A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting Conditions (NCT03898011) | Pharmtechnology LLC | 2019-03-23 |
| Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants (NCT03916250) | Pfizer | 2019-03-23 |
| Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis (NCT04219358) | Hospital de Clinicas de Porto Alegre | 2019-03-23 |
| Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions (NCT03898193) | Pharmtechnology LLC | 2019-03-23 |
| Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer (NCT03532451) | PrECOG, LLC. | 2019-03-22 |
| Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma Patients (NCT03904628) | Lee's Pharmaceutical Limited | 2019-03-22 |
| Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults (NCT03706261) | Adam Brickman | 2019-03-22 |
| Safety Study of Dengushield in Healthy Adults (NCT03883620) | Serum Institute of India Pvt. Ltd. | 2019-03-22 |
| Woodsmoke Particulate + Prednisone (NCT03861390) | University of North Carolina, Chapel Hill | 2019-03-22 |
| Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects (NCT04493281) | Shionogi | 2019-03-22 |
| Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure (NCT03860155) | RHEACELL GmbH & Co. KG | 2019-03-22 |
| Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours (NCT03894540) | Ipsen | 2019-03-22 |
| Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC (NCT03790228) | Henan Cancer Hospital | 2019-03-22 |
| Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblastoma (NCT03707457) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-22 |
| MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)or NF1-mutant(1b) (NCT03932253) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2019-03-21 |
| A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects (NCT04471922) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-03-21 |
| Study of Oral PQR309 in Patients With Advanced Solid Tumors (NCT02483858) | PIQUR Therapeutics AG | 2019-03-21 |
| 'ADVANCE' (A Pilot Trial) (NCT03858322) | Dana-Farber Cancer Institute | 2019-03-21 |
| Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC (NCT04293679) | Sirnaomics | 2019-03-21 |
| BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination. (NCT03867942) | LG Chem | 2019-03-21 |
| NEOBREADS: Neoadjuvant Breast Diet Study (NCT03822715) | Monica Mita | 2019-03-21 |
| HIV-1 Specific T -Cells (HST-NEETs) for HIV-Infected Individuals (NCT03485963) | Catherine Bollard | 2019-03-21 |
| Relative Bioavailability of NXP001 Compared to Emend® in Healthy Volunteers (NCT03889366) | Nuformix Technologies Limited | 2019-03-20 |
| TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers (NCT03829436) | Tempest Therapeutics | 2019-03-20 |
| A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State (NCT03882255) | Janssen Pharmaceutica N.V., Belgium | 2019-03-20 |
| Feasibility of the LUM Imaging System for Detection of Prostate Cancer (NCT03441464) | Lumicell, Inc. | 2019-03-20 |
| Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris (NCT04134273) | Sun Pharmaceutical Industries, Inc. | 2019-03-20 |
| Pharmacokinetics of New HepBQuin (NCT03899142) | Prothya Biosolutions | 2019-03-20 |
| Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer (NCT03860272) | Agenus Inc. | 2019-03-20 |
| Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab) (NCT03849313) | Alvotech Swiss AG | 2019-03-20 |
| Platelet Enriched Plasma for Treatment of Interstitial Cystitis (NCT04118946) | Mansoura University | 2019-03-20 |
| A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood (NCT03871595) | Boehringer Ingelheim | 2019-03-20 |
| Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer (NCT03770689) | EMD Serono Research & Development Institute, Inc. | 2019-03-20 |
| Follow on Extension of XT-150-1-0201 (NCT03769662) | Xalud Therapeutics, Inc. | 2019-03-20 |
| A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (NCT03845166) | Exelixis | 2019-03-20 |
| Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC) (NCT03324373) | Yousef Zakharia | 2019-03-20 |
| NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment (NCT03482167) | University of Delaware | 2019-03-20 |
| Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions (NCT04228653) | Renishaw | 2019-03-20 |
| Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma (NCT03799744) | Institut Català d'Oncologia | 2019-03-20 |
| Safety & Immunogenicity Study of Ad5 Based Oral Norovirus Vaccines (NCT03897309) | Vaxart | 2019-03-20 |
| Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens (NCT03816137) | Imperial College London | 2019-03-19 |
| Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma (NCT03787602) | Kartos Therapeutics, Inc. | 2019-03-19 |
| EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors (NCT03638167) | Seattle Children's Hospital | 2019-03-19 |
| Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma (NCT04119674) | Zhejiang Cancer Hospital | 2019-03-19 |
| A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT03787498) | Opna Bio LLC | 2019-03-19 |
| Relative Bioavailability and Bioequivalence of Opicapone (NCT03820037) | Bial - Portela C S.A. | 2019-03-19 |
| First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors (NCT03869632) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2019-03-19 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the Blood (NCT03843151) | Boehringer Ingelheim | 2019-03-19 |
| A Study Designed to Evaluate the Safety and Pharmacokinetics of Intravenously Administered Superoxide Dismutase Mimetic GC4711 in Healthy Volunteers (NCT03762031) | Galera Therapeutics, Inc. | 2019-03-19 |
| Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant (NCT03922061) | University of Vermont | 2019-03-19 |
| 68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer (NCT03831711) | Andrei Iagaru | 2019-03-19 |
| Mechanisms of Ozone-Induced Alterations in Efferocytosis and Phagocytosis (NCT03646877) | Robert Tighe, MD | 2019-03-19 |
| iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study (NCT04744532) | Kyoto University | 2019-03-19 |
| Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies (NCT03834272) | Lumicell, Inc. | 2019-03-18 |
| Study of Selumetinib (MK-5618) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (MK-5618-001) (NCT03833427) | Merck Sharp & Dohme LLC | 2019-03-18 |
| A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy Subjects (NCT03884491) | H. Lundbeck A/S | 2019-03-18 |
| Effect of PRP Injection in Releiving of Symptoms of Senile Vaginitis (NCT03898401) | Ain Shams University | 2019-03-18 |
| Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies (NCT03447470) | Redx Pharma Ltd | 2019-03-18 |
| A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease (NCT03888716) | Abliva AB | 2019-03-18 |
| Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth (NCT03874572) | Rigshospitalet, Denmark | 2019-03-18 |
| Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions (NCT02956512) | Apsen Farmaceutica S.A. | 2019-03-18 |
| Subcutaneous Elafin in Healthy Subjects (NCT03522935) | Roham T. Zamanian | 2019-03-18 |
| The Evaluation of Safety and Tolerance of Commercially Available Naltrexone Administered Daily - Assessment for CBRN Operations (NCT03879460) | Timothy Smith | 2019-03-18 |
| A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants (NCT03859219) | UCB Biopharma S.P.R.L. | 2019-03-18 |
| A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer (NCT03819387) | Nitto BioPharma, Inc. | 2019-03-18 |
| Study to Evaluate APVO210 in Healthy Subjects, Patients With Psoriasis, and Patients With Ulcerative Colitis (NCT03768219) | Aptevo Therapeutics | 2019-03-18 |
| Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects (NCT03794180) | I-Mab Biopharma US Limited | 2019-03-18 |
| Dose Escalating Study of Intramuscular Invaplex[AR-DETOX] (NCT03869333) | PATH | 2019-03-18 |
| PK of BDP/FF/GB Single-inhaler Triple Therapy in Japanese vs. Caucasians (NCT03859414) | Chiesi Farmaceutici S.p.A. | 2019-03-18 |
| A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies (NCT03797261) | AbbVie | 2019-03-18 |
| Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults (NCT03956524) | EuBiologics Co.,Ltd | 2019-03-16 |
| BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) (NCT03771885) | Boehringer Ingelheim | 2019-03-16 |
| Evaluation of Safety and Efficacy of realSKIN® (Skin Xenotransplant) for Complete Closure of Severe Burn Wounds (NCT03695939) | XenoTherapeutics, Inc. | 2019-03-15 |
| Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer (NCT03884517) | Bio-Thera Solutions | 2019-03-15 |
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects (NCT04084184) | Hanmi Pharmaceutical Company Limited | 2019-03-15 |
| A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated. (NCT03854552) | Boehringer Ingelheim | 2019-03-15 |
| Calcium Chloride for Prevention of Uterine Atony During Cesarean (NCT03867383) | Stanford University | 2019-03-15 |
| Phase 1 Trial of ASTX727 in Subjects With Lower-risk Myelodysplastic Syndromes (NCT03906695) | Otsuka Pharmaceutical Co., Ltd. | 2019-03-15 |
| DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer (NCT03879798) | Memorial Sloan Kettering Cancer Center | 2019-03-15 |
| Tocotrienols for Obesity of Postmenopausal Women (NCT03705845) | Texas Tech University Health Sciences Center | 2019-03-15 |
| A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL (NCT03740529) | Loxo Oncology, Inc. | 2019-03-15 |
| A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors (NCT03854227) | Pfizer | 2019-03-14 |
| Imaging with [89Zr]Panitumumab-PET/MRI in Patients with Newly Diagnosed Colorectal Cancer (NCT03764137) | University of Alabama at Birmingham | 2019-03-14 |
| A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect (NCT05486195) | AbbVie | 2019-03-14 |
| A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001) (NCT03833180) | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2019-03-14 |
| An Open-label, Dose Escalation Study in Japanese Participants With Relapsed/Refractory Multiple Myeloma Who Have Failed Prior Anti Myeloma Treatments (NCT03828292) | GlaxoSmithKline | 2019-03-14 |
| First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism (NCT03927508) | Thrombolex, Inc. | 2019-03-14 |
| Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A (NCT03890302) | Fountain Biopharma Inc. | 2019-03-14 |
| Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects (NCT03870490) | Venatorx Pharmaceuticals, Inc. | 2019-03-14 |
| Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT03848845) | GlaxoSmithKline | 2019-03-14 |
| A Study to Investigate the Effects of ACT-541468 on Nighttime Respiratory Function in Patients With Mild to Moderate Obstructive Sleep Apnea (NCT03765294) | Idorsia Pharmaceuticals Ltd. | 2019-03-14 |